1. Transplantation routes affect the efficacy of human umbilical cord mesenchymal stem cells in a rat GDM model
   Dan Wu et al, 2017, Clinica Chimica Acta CrossRef
2. Serum Betatrophin Concentrations and the Risk of Incident Diabetes: A Nested Case-Control Study from Chungju Metabolic Disease Cohort
   Seung-Hwan Lee et al, 2018, Diabetes Metab J CrossRef
3. The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the in vivo Treatment of Immune-Related Diseases: A Systematic Review
   Alessander Leyendecker Jr. et al, 2018, Front. Immunol. CrossRef
4. The Role of Natural-Based Biomaterials in Advanced Therapies for Autoimmune Diseases
   Helena Ferreira et al, 2018 CrossRef
5. Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus
   Hiroyuki Takahashi et al, 2019, JCM CrossRef
6. Bacteria-Derived Recombinant Human ANGPTL8/Betatrophin Significantly Increases the Level of Triglyceride
   Fangfang Xu et al, 2019, Protein J CrossRef
7. Insulin-Producing Cell Transplantation Platform for Veterinary Practice
   Suryo Kuncorojakti et al, 2020, Front. Vet. Sci. CrossRef
8. Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
   Jing Xue et al, 2020, Stem Cells International CrossRef
9. Recombinant betatrophin (Angptl‑8/lipasin) ameliorates streptozotocin‑induced hyperglycemia and β‑cell destruction in neonatal rats
   Di Zhang et al, 2019, Mol Med Report CrossRef
10. Mesenchymal Stem Cell-Based Therapy for Diabetes Mellitus: Enhancement Strategies and Future Perspectives
    Haisen Li et al, 2021, Stem Cell Rev and Rep CrossRef
11. The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?
    Wei Gong et al, 2021, BMC Women's Health CrossRef
12. Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
    Qiulan Huang et al, 2021, International Journal of Endocrinology CrossRef
13. Gene Therapy Based on Mesenchymal Stem Cells Derived from Adipose Tissue for the Treatment of Obesity and Its Metabolic Complications
    Marta Lopez-Yus et al, 2023, IJMS CrossRef
14. Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus.
    Agnieszka Mikłosz et al, 2023, J Clin Endocrinol Metab CrossRef
15. Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements
    Raziye Tajali et al, 2023, J Diabetes Metab Disord CrossRef
16. Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
    Priyamvada Amol Arte et al, 2023, Human Cell CrossRef
17. Emerging insights into the roles of ANGPTL8 beyond glucose and lipid metabolism
    Huimin Ye et al, 2023, Front. Physiol. CrossRef
18. Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications
    Dongxu Yan et al, 2024, Stem Cell Res Ther CrossRef
19. Immunomodulatory Properties of Adipose Derived-Stem Cells: Current State and Future Perspectives
    Adriana Grigoras et al, 2024 CrossRef
20. Advancing diabetes management: Exploring pancreatic beta-cell restoration’s potential and challenges
    Mona Mohamed Ibrahim Abdalla, 2024, World J Gastroenterol CrossRef
21. Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives
    Alaa Zeinhom et al, 2024, Stem Cell Res Ther CrossRef
22. Osteopontin Levels in Maternal Serum, Cord Blood, and Breast Milk According to Gestational Diabetes Mellitus: A Case-Control Study
    Merve Küçükoğlu Keser et al, 2024, Nutrients CrossRef
23. Research advance in mesenchymal stem cell-based therapy for diabetic nephropathy
    Yan Hui et al, 2024, Archives of Physiology and Biochemistry CrossRef